Cipher Pharmaceuticals (TSE:CPH) Stock Price Passes Below 50-Day Moving Average – Here’s Why

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$15.58 and traded as low as C$14.31. Cipher Pharmaceuticals shares last traded at C$14.77, with a volume of 20,934 shares.

Cipher Pharmaceuticals Stock Performance

The company has a market cap of C$368.77 million, a P/E ratio of 12.96 and a beta of 1.05. The company’s fifty day moving average is C$15.52 and its 200 day moving average is C$16.52. The company has a current ratio of 1.59, a quick ratio of 2.67 and a debt-to-equity ratio of 0.27.

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) last announced its quarterly earnings data on Tuesday, August 11th. The company reported C$0.21 earnings per share (EPS) for the quarter. Cipher Pharmaceuticals had a return on equity of 22.74% and a net margin of 58.81%.The firm had revenue of C$17.14 million for the quarter. As a group, equities analysts predict that Cipher Pharmaceuticals Inc. will post 1.2907348 earnings per share for the current fiscal year.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.